AWAYSIS CAPITAL, INC. financials

AWCA CIK 0001021917

Source: EDGAR filings · Built 2026-06-19T02:01:05Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2022FY 2015
Free Cash Flow -5.85M 500.55K -311.89K -179.79K
EBITDA -2.59M -6.99M -4.29M
Working Capital 152.93K 6.73M 5.74M 8.96M -25.36K -2.10M
Net Debt 3.67M 3.23M 2.94M 2.40M
Operating Margin -612.05% -13861.07% -3986.69%
Net Margin -617.82% -13926.10% -3986.12%
Return on Equity (ROE) -50.74% -91.83% -73.01% -2.67% 57.21% 25.14%
Return on Assets (ROA) -15.58% -56.53% -36.61% -2.01% -7255.50% -15003.27%
Current Ratio 1.01× 2.46× 2.03× 4.05× 0.01× 0.00×
Debt-to-Equity 0.73× 0.52× 0.50× 0.32×
Cash Conversion Ratio 1.76× -0.07× 0.06× 0.66× 0.41× 0.09×
Accruals Ratio 0.12× -0.61× -0.34× -0.01× -42.94× -136.79×
SBC % of Revenue 56.35% 17479.73% 104.45%
CapEx Coverage -4.61× 196.99× -4.71× -7.12×
Free Cash Flow Per Share $-0.02 $0.00 $-0.00 $-0.00

Income Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2022FY 2015
Revenue from Contract with Customer, Excluding Assessed Tax 441.06K 50.67K 107.76K
Operating Expenses 3.14M 7.07M 4.40M 239.85K 12.02K
Operating Income (Loss) -2.70M -7.02M -4.30M -239.85K -12.02K
Net Income (Loss) Attributable to Parent -2.72M -7.06M -4.30M -239.85K -14.51K -528.41K
Earnings Per Share, Basic $-0.01 $-0.02 $-0.03 $0.00 $0.00
Weighted Average Number of Shares Outstanding, Basic 376.22M 292.97M 162.78M 98.96M 98.88M
Earnings Per Share, Diluted $-0.01 $-0.02 $-0.03 $0.00
Weighted Average Number of Shares Outstanding, Diluted 376.22M 292.97M 162.78M 98.96M

Balance Sheet

Concept FY 2025FY 2024FY 2023FY 2022FY 2022FY 2015
Cash and Cash Equivalents, at Carrying Value 79 481.96K 195
Assets, Current 12.16M 11.35M 11.34M 11.89M 200 3.52K
Assets 17.49M 12.48M 11.73M 11.92M 200 3.52K
Liabilities, Current 12.01M 4.62M 5.60M 2.93M 25.56K 2.11M
Liabilities 12.12M 4.80M 5.85M 2.93M 25.56K 2.11M
Stockholders' Equity Attributable to Parent 5.37M 7.68M 5.88M 8.98M -25.36K -2.10M
Common Stock, Shares, Outstanding 385.18M 383.96M 252.23M 99.75M 98.88M 98.88M

Cash Flow Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2022FY 2015
Net Cash Provided by (Used in) Operating Activities -4.81M 503.11K -257.25K -157.65K -5.92K
Payments to Acquire Property, Plant, and Equipment 1.04M 2.55K 54.63K 22.14K
Net Cash Provided by (Used in) Investing Activities -1.04M -857.20K -29.63K -22.14K
Net Cash Provided by (Used in) Financing Activities 5.33M 1.10M -195.00K 661.75K 5.92K

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (AWCA CIK 0001021917), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

PTPI

Petros Pharmaceuticals, Inc.

ANGO

AngioDynamics, Inc.

GPCR

Structure Therapeutics Inc.